Cancer Antigen 19-9 (CA 19-9)

Product Name	Cancer Antigen 19-9
Source	Human Liver Metastases
Catalogue Number	151-99
Purity	Highly Purified
Form	Liquid
Activity	Typically > 500 kU/mL (Roche Elecsys EIA)
Purity Note	High purity, low cross contamination of other cancer antigens
Purification	Gel filtration & ion-exchange chromatography
Formulation	Solution in phosphate buffered saline, pH 7.4 with sucrose and 0.05% sodium azide.
Appearance	Clear and Colorless
Pairing Information	Capture Ab: 151-91 - anti-Human CA 19-9 Monoclonal Antibody Detection Ab: 151-92 - anti-Human CA 19-9 Monoclonal Antibody Antigen: 151-99 - CA 19-9 from human metastatic liver
Storage	-20°C
Recertification	3 years
Related Products	151-25 - CA-125 antigen from human ascites fluid 151-53 - CA 15-3 antigen from human ascites fluid 151-10 - CEA antigen from human liver
Infectious Disease Testing	Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods.
Synonyms	Tumor Marker 19-9, CA 19-9, Cancer Antigen 19-9, carbohydrate antigen 19-9, Sialylated Lewis (a) Antigen
Product Specificity	Gastrointestinal, Pancreatic Cancer